35 zoekresultaten voor “arthritis” in de Publieke website
-
cell-mediated immune modulation in experimental Rheumatoid Arthritis and Atherosclerosis
In this research project, we aimed to obtain more insight in the role of mast cells in the immune driven disorders rheumatoid arthritis and atherosclerosis.
-
Antisense Oligonucleotide Mediated Exon Skipping Based Therapies in Arthritis
Promotor: G.J.B. van Ommen
-
Reumatologie, i.h.b. vroege arthritis
Oratie
-
Systems diagnosis in chronic disease: prediction and evaluation
Promotor: J. van der Greef, T. Hankemeier; Co-promotor: H.A. van Wietmarschen
-
Anti-Carbamylated protein antibodies in Rheumatoid Arthritis
Promotie
-
of methodology in assessing inflammation and damage in rheumatoid arthritis and axial spondyloarthritis
Promotie
-
Monitoring rheumatoid arthritis
Promotie
-
Towards prevention of Rheumatoid Arthritis
Promotie
-
Early identification of rheumatoid arthritis
Promotie
-
Early identification and resolution of rheumatoid arthritis
Promotie
-
Worldwide Treatment Opportunities of Rheumatoid Arthritis
Promotie
-
Tolerance and Immune Regulation in Rheumatoid Arthritis
Promotie
-
Juvenile Idiopathic Arthritis: towards improving clinical care
Promotie
-
Clinically suspect arthralgia and early rheumatoid arthritis
Promotie
-
Unravelling the anti-carbamylated protein antibody response in rheumatoid arthritis
Promotie
-
The use of MRI in early inflammatory arthritis
Promotie
-
MRI in Early Rheumatoid Arthritis: Techniques and Applications
Promotie
-
Improving targeted treatment in early rheumatoid and undifferentiated arthritis
Promotie
-
Comprehending the symptomatic phase preceding Rheumatoid Arthritis: Clinically Suspect Arthralgia
Promotie
-
Functional aspects of the adaptive immune system in arthritis
Promotie
-
MRI-detected inflammation for early identification of inflammatory arthritis
Promotie
-
Antibody immune response and its effector functions in Rheumatoid Arthritis
Promotie
-
Protein Antibodies-IgG Variable Domain Glycosylation in Rheumatoid Arthritis
Promotie
-
The course of Clinically Suspect Arthralgia and Early Rheumatoid Arthritis: Clinical features, imaging and genetics
Promotie
-
Mast cell mediated immune modulation in experimental Rheumatoid Arthritis and atherosclerosis
Promotie
-
Immune regulation by CD4+CD49b+ T cells & B cell responses in arthritis
Promotie
-
Antisense Oligonucleotide Mediated Exon Skipping Based Therapies in Arthritis
Promotie
-
protein antibody (ACPA)-producing B cells in patients with rheumatoid arthritis (RA)
Promotie
-
response and toxicity to drugs used in autoimmune diseases: Rheumatoid arthritis and Systemic lupus erythematosus
Promotie
-
Chemical tools to study the cannabinoid receptor type 2
The cannabinoid receptor type 2 (CB2R) is associated with several inflammatory diseases with an unmet medical need (e.g. Alzheimers, multiple sclerosis, reumatoid arthritis). Development of new chemical biology strategies to study this protein is essential to aid future development of drugs for these…
-
The road to insurmountability: Novel avenues to better target CC Chemokine receptors
This thesis explores different avenues to develop insurmountable antagonists for CC Chemokine Receptors, such as CCR1, CCR2 and CCR5.
-
Systems diagnosis of chronic diseases, explored by metabolomics and ultra-weak photon emission
Promotor: J. van der Greef; Co-promotor: E. van Wijk, M. Wang
-
Population Health Management Excellence programme
De gezondheidszorg wordt geconfronteerd met een vergrijzende bevolking, stijgende kosten voor gezondheidszorg, een versnipperd zorgaanbod en de opkomst van medische technologieën en IT-systemen. Professionals in de gezondheidszorg hebben nieuwe competenties nodig en moeten worden uitgerust om deze uitdagingen…
-
Leids Universitair Medisch Centrum
In het Leids Universitair Medisch Centrum (LUMC) streven we naar de verbetering van de gezondheidszorg en de gezondheid van mensen.
-
Veni-beurzen voor 19 jonge Leidse onderzoekers
Negentien pas gepromoveerde onderzoekers van de Universiteit Leiden ontvangen een Veni-beurs van maximaal 250.000 euro. Wetenschapsfinancier NWO kent in deze financieringsronde in totaal 158 Veni-beurzen toe; de Universiteit Leiden heeft daarvan een aandeel van 12 procent.